We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.5B
AUM Growth
+$1.31B
Cap. Flow
-$64.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.13%
Holding
1,270
New
254
Increased
410
Reduced
389
Closed
206

Top Buys

Rank Stock Value
1
WCN
Waste Connections
WCN
+$102M
2
BNS icon
Scotiabank
BNS
+$91M
3
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$86.6M
4
TRI icon
Thomson Reuters
TRI
+$83.5M
5
KGC icon
Kinross Gold
KGC
+$53.5M

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$115M
2
ENB icon
Enbridge
ENB
+$87.8M
3
PFE icon
Pfizer
PFE
+$80.4M
4
CNI icon
Canadian National Railway
CNI
+$78.6M
5
AAPL icon
Apple
AAPL
+$73.1M

Sector Composition

Rank Sector Weight
1 Financials 24.6%
2 Technology 17.8%
3 Industrials 12.95%
4 Communication Services 8.37%
5 Materials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQNR icon
851
Equinor
EQNR
$96.4B
$384K ﹤0.01%
+14,590
New +$385K
OVID icon
852
Ovid Therapeutics
OVID
$521M
$384K ﹤0.01%
119,573
-80,000
-40% -$274K
IBKR icon
853
Interactive Brokers
IBKR
$41.5B
$383K ﹤0.01%
+19,268
New +$359K
OZON
854
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$383K ﹤0.01%
12,925
-15,151
-54% -$626K
HBIO icon
855
Harvard Bioscience
HBIO
$30.3M
$382K ﹤0.01%
5,425
-1,506
-22% -$107K
ACR
856
ACRES Commercial Realty
ACR
$100M
$381K ﹤0.01%
30,554
-5,741
-16% -$83.2K
CTT
857
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$379K ﹤0.01%
+43,489
New +$387K
MDGL icon
858
Madrigal Pharmaceuticals
MDGL
$11.8B
$377K ﹤0.01%
4,445
+1,871
+73% +$154K
SNV
859
DELISTED
Synovus
SNV
$377K ﹤0.01%
+7,882
New +$373K
RELX icon
860
RELX
RELX
$60.4B
$370K ﹤0.01%
11,348
-9,937
-47% -$309K
CENX icon
861
Century Aluminum
CENX
$4.6B
$368K ﹤0.01%
22,238
-8,632
-28% -$126K
EVBN
862
DELISTED
Evans Bancorp Inc
EVBN
$367K ﹤0.01%
9,113
-937
-9% -$37.1K
TBPH icon
863
Theravance Biopharma
TBPH
$878M
$365K ﹤0.01%
33,034
-11,203
-25% -$97.6K
DCPH
864
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$363K ﹤0.01%
+37,128
New +$698K
DAKT icon
865
Daktronics
DAKT
$986M
$350K ﹤0.01%
+69,336
New +$365K
MPB icon
866
Mid Penn Bancorp
MPB
$971M
$350K ﹤0.01%
11,013
+160
+1% +$4.75K
DLTH icon
867
Duluth Holdings
DLTH
$151M
$337K ﹤0.01%
22,188
+11,473
+107% +$173K
LFVN icon
868
LifeVantage
LFVN
$81.9M
$336K ﹤0.01%
53,158
-631
-1% -$4.29K
ONC
869
BeOne Medicines Ltd
ONC
$40.3B
$335K ﹤0.01%
+1,235
New +$417K
RELL icon
870
Richardson Electronics
RELL
$299M
$334K ﹤0.01%
24,702
-6,778
-22% -$78.2K
SJM icon
871
J.M. Smucker
SJM
$12.9B
$331K ﹤0.01%
2,440
-5,240
-68% -$668K
KDNY
872
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$331K ﹤0.01%
+20,266
New +$288K
BDSI
873
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$330K ﹤0.01%
106,371
+40,765
+62% +$137K
EXTN
874
DELISTED
Exterran Corporation
EXTN
$329K ﹤0.01%
110,464
+1,049
+1% +$4.15K
PHR icon
875
Phreesia
PHR
$783M
$328K ﹤0.01%
7,885
-2,185
-22% -$130K
33 34
35
36 37

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 Portfolio in Review

As of Q4 2021, Connor, Clark & Lunn Investment Management (CC&L) held 1,270 positions worth $20.5B, up 6.8% from $19.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 filing shows 254 new, 410 increased, 389 reduced and 206 closed positions. Its largest new stake was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M. The largest sale was Royal Bank of Canada, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2021 buy was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Waste Connections in Q4 2021, an estimated $102M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2021 reduction was Royal Bank of Canada, cutting an estimated $115M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q4 2021, selling an estimated $26.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $20.5B portfolio in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 254 new positions and closed 206 in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 6.8% quarter-over-quarter to $20.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.